Literature DB >> 15056385

High expression of myeloid-related proteins 8 and 14 characterizes an inflammatorily active but ineffective response of macrophages during leprosy.

Cord H Sunderkötter1, Jane Tomimori-Yamashita, Verena Nix, Solange M Maeda, Anca Sindrilaru, Mario Mariano, Clemens Sorg, Johannes Roth.   

Abstract

Macrophages are decisive cells for the course of leprosy as they phagocytose Mycobacterium leprae and have the potential to influence the specific immune response. Expression and release of the myeloid-related protein (MRP) 8 and MRP14 (S100A8 and S100A9) characterize a proinflammatory subtype of macrophage that is prominent in, for example, murine infection with lack of a T helper 1 cell response and in certain highly active chronic inflammations of mice and humans. We investigated cutaneous biopsies of the different forms of leprosy (41 untreated patients) including leprosy reaction type 1 (reversal reaction) and type 2 (erythema nodosum leprosum) (n = 18) for expression of MRP8 and MRP14 by subtypes of macrophages. Concomitantly we determined serum levels of MRP8 and MRP14 by sandwich enzyme-linked immunosorbent assay. Expression of MRP8 and MRP14 by CD68-positive macrophages was low in tuberculoid leprosy and rose significantly in borderline tuberculoid leprosy and especially in multibacillary forms, there being expressed by mycobacteria-loaded foam cells. A significant rise of MRP8 and MRP14 expression also occurred in lepra reactions compared to the corresponding non-reactional forms. In type 2 reactions this additional increase was associated with a significant elevation of serum levels. In type 1 it was associated with expression of MRP8 and MRP14 by epitheloid and giant cells, which so far were considered not to express both proteins. In conclusion, we present evidence that the two prominent proteins MRP8 and MRP14 can be re-expressed in vivo by tissue macrophages in chronic infection, that their increased expression is characteristic for a macrophage subtype associated with high inflammatory but low antimycobacterial activity in the absence of a T helper 1 response, and that their significant rise in serum during erythema nodosum leprosum bears diagnostic and pathophysiological relevance.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15056385      PMCID: PMC1782447          DOI: 10.1111/j.0019-2805.2004.01836.x

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  47 in total

1.  Expression and complex formation of S100-like proteins MRP8 and MRP14 by macrophages during renal allograft rejection.

Authors:  M Goebeler; J Roth; F Burwinkel; E Vollmer; W Böcker; C Sorg
Journal:  Transplantation       Date:  1994-08-15       Impact factor: 4.939

2.  MRP8 and MRP14, S-100-like proteins associated with myeloid differentiation, are translocated to plasma membrane and intermediate filaments in a calcium-dependent manner.

Authors:  J Roth; F Burwinkel; C van den Bos; M Goebeler; E Vollmer; C Sorg
Journal:  Blood       Date:  1993-09-15       Impact factor: 22.113

3.  Increased macrophage subset in inflammatory bowel disease: apparent recruitment from peripheral blood monocytes.

Authors:  J Rugtveit; P Brandtzaeg; T S Halstensen; O Fausa; H Scott
Journal:  Gut       Date:  1994-05       Impact factor: 23.059

Review 4.  Mechanisms generating functionally heterogeneous macrophages: chaos revisited.

Authors:  M S Rutherford; A Witsell; L B Schook
Journal:  J Leukoc Biol       Date:  1993-05       Impact factor: 4.962

5.  Molecular cloning of CD68, a human macrophage marker related to lysosomal glycoproteins.

Authors:  C L Holness; D L Simmons
Journal:  Blood       Date:  1993-03-15       Impact factor: 22.113

6.  Measurement of plasma calprotectin as an indicator of arthritis and disease activity in patients with inflammatory rheumatic diseases.

Authors:  J G Brun; R Jonsson; H J Haga
Journal:  J Rheumatol       Date:  1994-04       Impact factor: 4.666

7.  Resistance of mice to experimental leishmaniasis is associated with more rapid appearance of mature macrophages in vitro and in vivo.

Authors:  C Sunderkötter; M Kunz; K Steinbrink; G Meinardus-Hager; M Goebeler; H Bildau; C Sorg
Journal:  J Immunol       Date:  1993-11-01       Impact factor: 5.422

Review 8.  Macrophages and angiogenesis.

Authors:  C Sunderkötter; K Steinbrink; M Goebeler; R Bhardwaj; C Sorg
Journal:  J Leukoc Biol       Date:  1994-03       Impact factor: 4.962

Review 9.  MRP-8 and MRP-14, two abundant Ca(2+)-binding proteins of neutrophils and monocytes.

Authors:  P A Hessian; J Edgeworth; N Hogg
Journal:  J Leukoc Biol       Date:  1993-02       Impact factor: 4.962

10.  Lack of expression of intercellular adhesion molecule ICAM-1 in lepromatous leprosy patients.

Authors:  B Moncada; M B Torres-Alvarez; R Gonzalez-Amaro; C Fuentes-Ahumada; L Baranda; S P Delgado; R Garcia
Journal:  Int J Lepr Other Mycobact Dis       Date:  1993-12
View more
  6 in total

1.  [Cutaneous leishmaniasis].

Authors:  E von Stebut; C Sunderkötter
Journal:  Hautarzt       Date:  2007-05       Impact factor: 0.751

Review 2.  Cytokines in the host response to Candida vaginitis: Identifying a role for non-classical immune mediators, S100 alarmins.

Authors:  Junko Yano; Mairi C Noverr; Paul L Fidel
Journal:  Cytokine       Date:  2011-12-17       Impact factor: 3.861

Review 3.  [Skin manifestations of different forms of vasculitis].

Authors:  C Sunderkötter
Journal:  Z Rheumatol       Date:  2013-06       Impact factor: 1.372

Review 4.  Functions of S100 proteins.

Authors:  R Donato; B R Cannon; G Sorci; F Riuzzi; K Hsu; D J Weber; C L Geczy
Journal:  Curr Mol Med       Date:  2013-01       Impact factor: 2.222

Review 5.  A Systematic Review of Immunological Studies of Erythema Nodosum Leprosum.

Authors:  Anastasia Polycarpou; Stephen L Walker; Diana N J Lockwood
Journal:  Front Immunol       Date:  2017-03-13       Impact factor: 7.561

6.  Pathways and Genes Associated with Immune Dysfunction in Sheep Paratuberculosis.

Authors:  Anton Gossner; Craig Watkins; Francesca Chianini; John Hopkins
Journal:  Sci Rep       Date:  2017-04-24       Impact factor: 4.379

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.